6 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 55.7% per year over the past 5 years.
Operating margin has expanded, at -35.8% in the latest year.
Financial health
Operating income covered interest expense -2536.4× in the latest year, down from -69.4× 5 years ago.
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.0 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$134M
-$39
76.6%
-35.8%
-$19M
—
$20M
2024
$140M
-$28
70.7%
-26.3%
-$22M
—
$17M
2023
$89M
-$49
60.4%
-56.2%
-$46M
$0
$10M
2022
$49M
-$67
43.5%
-129.2%
-$61M
$40M
$12M
2021
$23M
-$49M
20.0%
-233.6%
-$47M
$40M
$24M
2020
$15M
$28M
11.6%
-241.3%
-$38M
$24M
$14M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$31M
-$16M
76.1%
-57.7%
-$12M
—
$18M
Dec '25
$33M
-$9M
77.5%
-34.8%
-$2M
—
$20M
Sep '25
$30M
-$10M
79.9%
-40.1%
-$2M
—
$30M
Jun '25
$34M
-$12M
74.9%
-41.6%
-$6M
—
$40M
Mar '25
$38M
-$8M
74.8%
-28.2%
-$9M
—
$28M
Dec '24
$40M
-$6M
71.6%
-21.5%
-$5M
—
$17M
Sep '24
$35M
-$6M
71.4%
-26.1%
-$453000
—
$17M
Jun '24
$35M
-$6M
69.5%
-23.9%
-$6M
—
$24M
Mar '24
$30M
-$9M
70.1%
-36.2%
-$11M
—
$33M
Dec '23
$29M
-$9M
61.8%
-38.0%
-$10M
$0
$10M
Sep '23
$22M
-$12M
61.9%
-56.4%
-$9M
$0
$10M
Jun '23
$21M
-$14M
57.7%
-65.5%
-$9M
$20M
$9M
Mar '23
$17M
-$13M
59.3%
-74.9%
-$19M
$40M
$11M
Dec '22
$16M
-$16M
46.1%
-93.2%
-$14M
$40M
$12M
Sep '22
$13M
-$17M
42.5%
-126.5%
-$16M
$40M
$9M
Jun '22
$11M
-$17M
42.1%
-139.0%
-$16M
$40M
$24M
Mar '22
$9M
-$18M
42.1%
-185.4%
-$15M
$40M
$24M
Dec '21
$8M
-$16M
34.0%
-174.0%
-$9M
$40M
$24M
Sep '21
$6M
-$13M
23.2%
-226.6%
-$14M
$40M
$68M
Jun '21
$5M
-$13M
-16.6%
-283.4%
-$13M
$40M
$42M
Valuation over time
How the market has priced RXST against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 14.1× (Mar '23) to 1.6× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is RXST growing its revenue and profit?
Over the past 5 years, Rxsight, Inc.'s revenue has grown 55.7% per year. These are computed facts, not advice.
How much debt does RXST have?
As of FY2025, Rxsight, Inc. reported — of total debt against $20M of cash; operating income covered interest expense -2536.4×.
What is RXST's profit margin?
In FY2025, gross margin was 76.6%, operating margin -35.8%, and net margin -0.0%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.